Literature DB >> 25801565

Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.

Sheila Adams-Sapper1, Shantell Nolen1, Grace Fox Donzelli1, Mallika Lal1, Kunihiko Chen1, Livia Helena Justo da Silva2, Beatriz M Moreira2, Lee W Riley3.   

Abstract

Enterobacteriaceae strains producing the Klebsiella pneumoniae carbapenemase (KPC) have disseminated worldwide, causing an urgent threat to public health. KPC-producing strains often exhibit low-level carbapenem resistance, which may be missed by automated clinical detection systems. In this study, eight Klebsiella pneumoniae strains with heterogeneous resistance to imipenem were used to elucidate the factors leading from imipenem susceptibility to high-level resistance as defined by clinical laboratory testing standards. Time-kill analysis with an inoculum as low as 3 × 10(6) CFU/ml and concentrations of imipenem 8- and 16-fold higher than the MIC resulted in the initial killing of 99.9% of the population. However, full recovery of the population occurred by 20 h of incubation in the same drug concentrations. Population profiles showed that recovery was mediated by a heteroresistant subpopulation at a frequency of 2 × 10(-7) to 3 × 10(-6). Samples selected 2 h after exposure to imipenem were as susceptible as the unexposed parental strain and produced the major outer membrane porin OmpK36. However, between 4 to 8 h after exposure, OmpK36 became absent, and the imipenem MIC increased at least 32-fold. Individual colonies isolated from cultures after 20 h of exposure revealed both susceptible and resistant subpopulations. Once induced, however, the high-level imipenem resistance was maintained, and OmpK36 remained unexpressed even without continued carbapenem exposure. This study demonstrates the essential coordination between blaKPC and ompK36 expression mediating high-level imipenem resistance from a population of bacteria that initially exhibits a carbapenem-susceptibility phenotype.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25801565      PMCID: PMC4432212          DOI: 10.1128/AAC.05100-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  57 in total

1.  In vivo acquisition of high-level resistance to imipenem in Escherichia coli.

Authors:  Laurent Poirel; Claire Héritier; Colette Spicq; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Role of ISKpn7 and deletions in blaKPC gene expression.

Authors:  Thierry Naas; Gaelle Cuzon; Ha-Vy Truong; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

3.  Whole-genome sequencing reveals a link between β-lactam resistance and synthetases of the alarmone (p)ppGpp in Staphylococcus aureus.

Authors:  Michael M Mwangi; Choonkeun Kim; Marilyn Chung; Jennifer Tsai; Govindan Vijayadamodar; Michelle Benitez; Thomas P Jarvie; Lei Du; Alexander Tomasz
Journal:  Microb Drug Resist       Date:  2013-05-09       Impact factor: 3.431

4.  Investigation of carbapenem heteroresistance among different sequence types of Pseudomonas aeruginosa clinical isolates reveals further diversity.

Authors:  Olga Oikonomou; Maria Panopoulou; Alexandros Ikonomidis
Journal:  J Med Microbiol       Date:  2011-05-19       Impact factor: 2.472

5.  The multiple paths to heteroresistance and intermediate resistance to vancomycin in Staphylococcus aureus.

Authors:  Stan Deresinski
Journal:  J Infect Dis       Date:  2013-03-28       Impact factor: 5.226

6.  Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.

Authors:  O Zarkotou; S Pournaras; P Tselioti; V Dragoumanos; V Pitiriga; K Ranellou; A Prekates; K Themeli-Digalaki; A Tsakris
Journal:  Clin Microbiol Infect       Date:  2011-05-20       Impact factor: 8.067

7.  The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.

Authors:  Ryan P Lamers; Joseph F Cavallari; Lori L Burrows
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

8.  Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus.

Authors:  Yoriko Harigaya; Dung Ngo; Alan J Lesse; Vanthida Huang; Brian T Tsuji
Journal:  BMC Infect Dis       Date:  2011-10-25       Impact factor: 3.090

9.  Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients.

Authors:  Yasmin Maor; Levona Lago; Amir Zlotkin; Yeshayahu Nitzan; Natasha Belausov; Debby Ben-David; Nathan Keller; Galia Rahav
Journal:  BMC Microbiol       Date:  2009-09-04       Impact factor: 3.605

10.  Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems.

Authors:  Yu-Kuo Tsai; Ci-Hong Liou; Chang-Phone Fung; Jung-Chung Lin; L Kristopher Siu
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more
  20 in total

1.  Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam.

Authors:  Krystyna M Kazmierczak; Douglas J Biedenbach; Meredith Hackel; Sharon Rabine; Boudewijn L M de Jonge; Samuel K Bouchillon; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases.

Authors:  Ryan K Shields; M Hong Nguyen; Ellen G Press; Liang Chen; Barry N Kreiswirth; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  Rapid Identification of Klebsiella pneumoniae by Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry and Detection of Meropenem Resistance by Flow Cytometric Assay.

Authors:  Abdullah Kilic; Eyup Dogan; Sinem Kaya; Sema Oren; Duran Tok; Nurittin Ardic; Mehmet Baysallar
Journal:  J Clin Lab Anal       Date:  2016-05-30       Impact factor: 2.352

4.  Klebsiella pneumoniae Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio.

Authors:  Maria V Golikova; Kamilla N Alieva; Alla V Filimonova; Vladimir A Ageevets; Ofeliia S Sulian; Alisa A Avdeeva; Sergey V Sidorenko; Stephen H Zinner
Journal:  Biomedicines       Date:  2022-06-20

5.  An Enzyme-Mediated Amplification Strategy Enables Detection of β-Lactamase Activity Directly in Unprocessed Clinical Samples for Phenotypic Detection of β-Lactam Resistance.

Authors:  Tara R deBoer; Nicole J Tarlton; Reina Yamaji; Sheila Adams-Sapper; Tiffany Z Wu; Santanu Maity; Giri K Vesgesna; Corinne M Sadlowski; Peter DePaola; Lee W Riley; Niren Murthy
Journal:  Chembiochem       Date:  2018-09-26       Impact factor: 3.164

6.  A rapid, antibiotic susceptibility test for multidrug-resistant, Gram-negative bacterial uropathogens using the biochemical assay, DETECT.

Authors:  Nicole Jackson; Clarissa A Borges; Nicole J Tarlton; Angel Resendez; Aubrianne K Milton; Tara R de Boer; Cheyenne R Butcher; Niren Murthy; Lee W Riley
Journal:  J Microbiol Methods       Date:  2021-02-04       Impact factor: 2.363

7.  A Dual Enzyme-Based Biochemical Test Rapidly Detects Third-Generation Cephalosporin-Resistant CTX-M-Producing Uropathogens in Clinical Urine Samples.

Authors:  Nicole J Tarlton; Danka-Florence Petrovic; Bradley W Frazee; Clarissa A Borges; Emily M Pham; Aubrianne K Milton; Nicole Jackson; Tara R deBoer; Niren Murthy; Lee W Riley
Journal:  Microb Drug Resist       Date:  2020-08-19       Impact factor: 3.431

8.  A Rapid Antimicrobial Susceptibility Test for Klebsiella pneumoniae Using a Broth Micro-Dilution Combined with MALDI TOF MS.

Authors:  Gang Wang; Guobin Song; Yuanhong Xu
Journal:  Infect Drug Resist       Date:  2021-05-14       Impact factor: 4.003

9.  In-Human Multiyear Evolution of Carbapenem-Resistant Klebsiella pneumoniae Causing Chronic Colonization and Intermittent Urinary Tract Infections: A Case Study.

Authors:  Michelle Kalu; Karen Tan; Marquerita Algorri; Peter Jorth; Annie Wong-Beringer
Journal:  mSphere       Date:  2022-05-09       Impact factor: 5.029

10.  A Phenotypic and Genotypic Analysis of the Antimicrobial Potential of Cultivable Streptomyces Isolated from Cave Moonmilk Deposits.

Authors:  Marta Maciejewska; Delphine Adam; Loïc Martinet; Aymeric Naômé; Magdalena Całusińska; Philippe Delfosse; Monique Carnol; Hazel A Barton; Marie-Pierre Hayette; Nicolas Smargiasso; Edwin De Pauw; Marc Hanikenne; Denis Baurain; Sébastien Rigali
Journal:  Front Microbiol       Date:  2016-09-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.